Spasticity
- 8 January 1981
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 304 (2) , 96-99
- https://doi.org/10.1056/nejm198101083040207
Abstract
DiazepamBenzodiazepines such as diazepam enhance presynaptic inhibition in the spinal cord of the cat by facilitating or potentiating the postsynaptic effects of gamma-aminobutyric acid (GABA)20 (Fig. 2, Part I). To do this, benzodiazepines interact with an allosteric protein modulator of GABA-recognition sites to increase these receptors' affinity for GABA, thereby rendering them more efficient in increasing chloride conductance across nerve membrane — a mechanism by which presynaptic and postsynaptic inhibition is mediated. Benzodiazepines may also act presynaptically to enhance the endogenous release of GABA or may depress postsynaptic excitatory responses mediated by glutamate.Benzodiazepines have no direct GABA-mimetic effect, . . .Keywords
This publication has 7 references indexed in Scilit:
- THE MODE OF ACTION OF THE GABA DERIVATIVE BACLOFEN IN HUMAN SPASTICITYActa Neurologica Scandinavica, 2009
- (–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptorNature, 1980
- Molecular Mechanisms in the Receptor Action of BenzodiazepinesAnnual Review of Pharmacology and Toxicology, 1979
- CLONUS DEPRESSION BY PROPRANOLOLActa Neurologica Scandinavica, 1976
- An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesionsNeurology, 1976
- THE PATHOLOGICAL ANATOMY OF POSTHEMIPLEGIC ATHETOSISBrain, 1975
- On the site of action of diazepam in spasticity in manJournal of the Neurological Sciences, 1967